Status:
COMPLETED
C2P - Phase III: MPowerment and Community Promise
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Conditions:
HIV Infections
Eligibility:
All Genders
12-24 years
Phase:
NA
Brief Summary
One of the objectives of the C2P coalition is the successful delivery of a CDC-endorsed community-level HIV prevention program aimed at changing the risk profiles of youth. This protocol (ATN 041) des...
Detailed Description
Community Promise: Role model stories comprise the "heart" of printed materials distributed throughout the target community. The role model stories are brief publications that depict personal accounts...
Eligibility Criteria
Inclusion
- Community Promise:
- Inclusion Criteria
- Adolescents and young adults who provide verbal confirmation that their age is within
- the range of 12 through 24 years, inclusive.
- Gender will reflect that of the population of focus.
- Must report having engaged in voluntary sexual activity within the past 12 months (vaginal, anal and/or oral sex).
- Ability to understand and willingness to provide informed consent/assent.
- Exclusion Criteria
- Visibly distraught and/or visibly emotionally unstable (e.g., depressive mood, or exhibiting manic, suicidal, or violent behavior).
- Visibly intoxicated or under the influence of psychoactive agents
- Clinically presents as acutely ill.
- MPowerment:
- Inclusion Criteria
- Male adolescents and young adults who provide verbal confirmation that their age is within the range of 12 through 24 years, inclusive.
- Must report having engaged in voluntary sexual activity within the past 12 months (anal and/or oral sex) with a man.
- Ability to understand and willingness to provide informed consent/assent.
- Exclusion Criteria
- Visibly distraught and/or visibly emotionally unstable (i.e., depressive mood,
- or exhibiting manic, suicidal, or violent behavior, etc.).
- Visibly intoxicated or under the influence of psychoactive agents.
- Clinically presents as acutely ill.
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00381784
Start Date
July 1 2006
End Date
March 1 2011
Last Update
March 3 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital of Los Angeles
Los Angeles, California, United States, 90054
2
University of California at San Francisco
San Francisco, California, United States, 94143
3
Childrens Hospital National Medical Center
Washington D.C., District of Columbia, United States, 20010
4
USF Peds Division of Infectious Disease
Tampa, Florida, United States, 33606